VISION-DMD

Designed to ensure a timely & cost-effective drug development for Duchenne muscular dystrophy

ReveraGen


Workpackage involvement

Follow us on twitter

EUFlag2020

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement number 667078.

To find out more about the project contact us at [email protected]